News
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...
The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.
Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score ...
“Banning NIH-funded researchers from publishing in leading medical journals and requiring them to publish only in journals that carry the RFK Jr. seal of approval would delegitimize taxpayer-funded ...
Topline results were announced from two phase 3 trials evaluating itepekimab, an anti-interleukin-33 monoclonal antibody, in former smokers with inadequately controlled chronic obstructive pulmonary ...
Nucala gains new indication; FDA implements stricter guidance for COVID-19 vaccine approval; pruritus reported following discontinuation of long-term antihistamines; antibiotic looks promising for ...
Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.
Odds of any acute cardiovascular event increased when compared with COVID-19 hospitalizations in boosted and unboosted individuals.
The announcement bypassed the usual review by the CDC’s Advisory Committee on Immunization Practices, a group that typically meets to review data and offer guidance on who should get a vaccine.
As of mid-May, this variant has been identified in nearly 11% of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently assesses the ...
The protest happened roughly 27 minutes into the meeting, held at NIH headquarters in Bethesda, Md. In a video obtained by CNN, Bhattacharya is shown telling staff that, based on his review of ...
The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results